Epigenetic alterations

Based on the provided literature, epigenetic alterations—particularly involving DNA methylation patterns—play a fundamental role in regulating gene expression and defining cellular identity [7]. Recent advancements in genomic resources, such as the NIH Roadmap Epigenomics Consortium's generation of 111 reference human epigenomes and analytical platforms like cBioPortal, have enabled the multidimensional exploration of these epigenetic events in both normal human tissues and pathological states like cancer [1, 6].

A major consensus in the field is that specific DNA methylation states can be harnessed to accurately estimate chronological and biological age across a broad spectrum of human tissues and cell types [8]. Furthermore, integrated analyses—such as those conducted on high-grade serous ovarian carcinomas—regularly incorporate promoter methylation alongside mRNA expression, microRNA expression, and DNA copy number variations to catalogue molecular aberrations [3].

Despite these descriptive frameworks, key open questions remain regarding the exact mechanisms and functional consequences of epigenetic memory [7], as well as whether DNA methylation age predictors are universally meaningful measures across all pathological contexts [8]. The strength of evidence supporting epigenetic profiling is high regarding reference maps [6] and multi-tissue age prediction models [8], though the field continues to evolve through integrative genomics linking epigenetic changes to disease states [1, 3].